Migdalia Cardona Cardona Negron, | |
Urb Las Delicias B6, Barceloneta, PR 00617 | |
(787) 846-4848 | |
Not Available |
Full Name | Migdalia Cardona Cardona Negron |
---|---|
Gender | Female |
Speciality | Emergency Medicine - Emergency Medical Services |
Location | Urb Las Delicias B6, Barceloneta, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720279508 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | 1626-2 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Migdalia Cardona Cardona Negron, P.o. Box 339, Barceloneta, PR 00617 Ph: (787) 846-4848 | Migdalia Cardona Cardona Negron, Urb Las Delicias B6, Barceloneta, PR 00617 Ph: (787) 846-4848 |
News Archive
Children with behavioral problems may have different compositions in their gut microbiome, with parents playing a major role in how pronounced the differences were, other than the food they provide, a new study suggests.
Rigel Pharmaceuticals, Inc. today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 relating to the license agreement between Rigel and AstraZeneca, the effectiveness of which was contingent on the expiration of the waiting period.
Researchers in the University of South Florida's Global Center for Hearing and Speech Research, recognized as the world's top research center for age-related hearing loss, have received a five-year, $9 million grant from the National Institutes of Health to study two unique ways to treat age-related hearing loss (ARHL).
A new study of airflow patterns inside a car's passenger cabin offers some suggestions for potentially reducing the risk of COVID-19 transmission while sharing rides with others.
University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed a software program that can accurately predict which tumor-specific markers will show up on the surface of leukemia cells in patients who have received stem cell transplants.
› Verified 1 days ago